IDEXX Laboratories, Inc. (LON:0J8P)
 724.30
 +90.16 (14.22%)
  At close: Nov 3, 2025
IDEXX Laboratories Revenue
IDEXX Laboratories had revenue of $1.11B USD in the quarter ending September 30, 2025, with 13.29% growth. This brings the company's revenue in the last twelve months to $4.17B, up 8.39% year-over-year. In the year 2024, IDEXX Laboratories had annual revenue of $3.90B with 6.46% growth.
Revenue (ttm) 
 $4.17B
Revenue Growth 
 +8.39%
P/S Ratio 
 14.19
Revenue / Employee 
 $378.86K
Employees 
 11,000
Market Cap 
44.00B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth | 
|---|---|---|---|
| Dec 31, 2024 | 3.90B | 236.55M | 6.46% | 
| Dec 31, 2023 | 3.66B | 293.63M | 8.72% | 
| Dec 31, 2022 | 3.37B | 151.96M | 4.73% | 
| Dec 31, 2021 | 3.22B | 508.71M | 18.79% | 
| Dec 31, 2020 | 2.71B | 299.75M | 12.45% | 
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue | 
|---|---|
| AstraZeneca | 41.24B | 
| GSK plc | 32.17B | 
| Haleon | 11.02B | 
| Smith & Nephew | 4.33B | 
| Hikma Pharmaceuticals | 2.35B | 
| ConvaTec Group | 1.72B | 
| Spire Healthcare Group | 1.55B | 
| Genus | 672.80M | 
IDEXX Laboratories News
- 3 days ago - IDEXX Laboratories (IDXX) Upgraded to Buy with Price Target of $700 - GuruFocus
 - 3 days ago - Pre-Market Earnings Report for November 3, 2025 : IDXX, PEG, RYAAY, ARES, BNTX, ON, CNA, PNW, CIFR, AMG, AXSM, BRKR - Nasdaq
 - 3 days ago - If You Invested $100 In IDEXX Laboratories Stock 10 Years Ago, You Would Have This Much Today - Benzinga
 - 3 days ago - IDXX: Stifel Upgrades IDEXX Laboratories with New Price Target | IDXX Stock News - GuruFocus
 - 3 days ago - This Hershey Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Friday - Benzinga
 - 7 days ago - Idexx Laboratories (IDXX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release - Nasdaq
 - 13 days ago - HOLX or IDXX: Which Is the Better Value Stock Right Now? - Nasdaq
 - 14 days ago - Here's How IDEXX Laboratories is Placed Ahead of Q3 Earnings - Nasdaq